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D Han3, H Habte3, Y Qin3, K Takamoto1, C LaBranche2, D Montefiori2 and MW Cho3*Retraction
This poster presentation [1] has been retracted on re-
quest of the author Michael W Cho. The Office of
Research Integrity at the US DHHS has determined that
the first author Dong-Pyou Han committed research
misconduct and the poster was prepared based on
falsified data [2].
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